ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pathogenesis and synovial fluid"

  • Abstract Number: 2047 • 2018 ACR/ARHP Annual Meeting

    Synovial Fluid Cytokines /Chemokines and Proteins from the Knees of Symptomatic RA and OA Patients Which Correlate with the Magnitude of the Inflammatory Response As Measured By Synovial Fluid WBC Levels

    Richard Meehan1, Eric Hoffman2, Mary Wolf3, Elizabeth Regan4, Prashant Parmar5, Karin Pacheco6, Jim Crooks7 and Vijaya Knight8, 1MEDICINE, National Jewish Health, Denver, CO, 2Medicine/Rheumatology, National Jewish Health, Denver, CO, 3Pathology Department, National Jewish Health, Denver, CO, 4Medicine, National Jewish Health, Denver, CO, 5Internal Medicine, St Joseph Hospital, Denver, CO, 6MEDICINE/ Occupational Medince, National Jewish Health, Denver, CO, 7Biostatistics, National Jewish Health, Denver, CO, 8Pathology, ADX laboratory, National Jewish Health, Denver, CO

    Background/Purpose: Synovial fluid (SF) provides nutritional support for cartilage and contains numerous catabolic and anabolic cytokines, chemokines and proteins. The precise role of these proteins…
  • Abstract Number: 2898 • 2018 ACR/ARHP Annual Meeting

    Increased Frequency of Circulating CD4+CXCR5-PD1hi Peripheral Helper T (cTph) Cells in Patients with Seropositive Early Rheumatoid Arthritis (RA)

    Paula Fortea-Gordo1, Laura Nuño2, Alejandro Villalba2, Diana Peiteado3, Irene Monjo4, Paloma Sanchez-Mateos5, Amaya Puig-Kröger6, Alejandro Balsa1 and Maria Eugenia Miranda-Carus1, 1Rheumatology, Hospital La Paz - IdiPAZ, Madrid, Spain, 2Rheumatology, La Paz University Hospital, Madrid, Spain, 3Hospital Universitario La Paz, Madrid, Spain, 4Rheumatology, Rheumatology, La Paz University Hospital, Madrid, Spain, 5Immunology, Hospital Gregorio Marañon, Madrid, Spain, 6Immuno-oncology, Hospital Gregorio Marañon, Madrid, Spain

    Background/Purpose: A novel population of CD4+ T cells with B cell helping capacity has been described in the synovial tissues and peripheral blood of seropositive…
  • Abstract Number: 1462 • 2014 ACR/ARHP Annual Meeting

    Cadherin-11 mRNA Expression in the Peripheral Blood of Rheumatoid Arthritis Patients As a Marker of Active Polyarthritis

    Petros P. Sfikakis1, Panagiotis F. Christopoulos1,2, Aristeidis G. Vaiopoulos1,2, Kalliopi Fragkiadaki1, Christina Katsiari3, Violetta Kapsimali4, George Lallas1, Panayiotis Panayiotidis4, Pinelopi Korkopoulou5 and Michael Koutsilieris2, 1First Department of Propedeutic Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, 2Department of Physiology, Athens University Medical School, Athens, Greece, 3Department of Rheumatology, School of Health Sciences, University of Thessaly, Larissa, Greece, 4Department of Microbiology, Athens University Medical School, Athens, Greece, 5Department of Pathology, Athens University Medical School, Athens, Greece

    Background/Purpose: Human rheumatoid arthritis synovial fibroblasts (RASF) implanted subcutaneously in immunodeficient mice trans-migrate through the vasculature and drive the progression from oligo- to poly-articular disease.…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology